On Wednesday, the Houston Texans announced that safety Andre Hal is in remission after undergoing treatments for Hodgkin lymphoma.
— Houston Texans (@HoustonTexans) September 26, 2018
“Today’s one of those days that is bigger than football,” Texans HC Bill O’Brien said, via ESPN.com. “[Andre] Hal, his Hodgkin’s lymphoma is in remission. Dre’s a very special guy to us here, he’s a very special guy to me. He’s been here from the start.
“He’s been a leader for us. He’s just been an unbelievable guy in this organization. Dre never wavered in his belief that he would beat it. And he has.”
“I’ve been working out the whole time,” Hal said. “I never stopped working out. I was obsessed. I wanted to get back on the field.”
However, Hal said he is still waiting to hear when he can be cleared to play again, per Aaron Wilson.
Hal, 26, is a former seventh-round pick of the Texans back in 2014. He was in the final year of his four-year, $2.28 million contract when he agreed to a three-year deal worth $15 million and includes $7 million guaranteed last year.
Hal stands to make base salaries of $3.25 million over the next three years of the agreement.
The Texans placed Hal on the Non-Football Illness list back in July.
In 2017, Hal appeared in all 16 games for the Texans and recorded 71 tackles, three interceptions, two forced fumbles and five pass defenses.